Some of these strongly suppressed KRAS expression in Panc-1, pancreatic cancer cells, and reduced the tumor xenograft growth in immunodeficient mice, increasing also their median survival time by 70% [164]. Here, KRAS is linked to familial pancreatic carcinoma.